Gainers
- Vroom, Inc. (NASDAQ:VRM) shares rose 38% to $1.49 in pre-market trading after the company reported better-than-expected Q1 results.
- Evolve Transition Infrastructure LP (NYSE:SNMP) rose 22.6% to $0.50 in pre-market trading after declining around 7% on Monday.
- Color Star Technology Co., Ltd. (NASDAQ:CSCW) rose 22.6% to $0.14 in pre-market trading after dropping 12% on Monday.
- Genocea Biosciences, Inc. (NASDAQ:GNCA) shares rose 16.1% to $0.23 in pre-market trading after dipping around 12% on Monday.
- Stealth BioTherapeutics Corp (NASDAQ:MITO) rose 15.6% to $0.2624 in pre-market trading after jumping 24% on Monday.
- Drive Shack Inc. (NYSE:DS) rose 15% to $1.30 in pre-market trading.
- NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) rose 14.8% to $0.5360 in pre-market trading after tumbling 23% on Monday.
- Clover Health Investments, Corp. (NASDAQ:CLOV) rose 14.8% to $2.77 in pre-market trading after the company reported better-than-expected Q1 sales results and reaffirmed its FY22 guidance.
- NewAge, Inc. (NASDAQ:NBEV) rose 14.4% to $0.40 in pre-market trading after declining around 8% on Monday.
- Biora Therapeutics (NASDAQ:BIOR) rose 13.8% to $0.8650 in pre-market trading following a 14% decline on Monday.
- Athenex, Inc. (NASDAQ:ATNX) rose 13.6% to $0.5299 in pre-market trading.
- Assertio Holdings, Inc. (NASDAQ:ASRT) rose 13.3% to $2.13 in pre-market trading after the company reported better-than-expected Q1 EPS and sales results.
- GoldMining Inc. (NYSE:GLDG) rose 13.1% to $1.21 in pre-market trading after dipping 10% on Monday.
- Himax Technologies, Inc. (NASDAQ:HIMX) rose 12.5% to $9.21 in pre-market trading.
- Sema4 Holdings Corp. (NASDAQ:SMFR) rose 12.1% to $2.13 in pre-market trading after dipping 22% on Monday.
- LivePerson, Inc. (NASDAQ:LPSN) rose 12% to $18.26 in pre-market trading following Q1 results.
- Nutex Health, Inc. (NASDAQ:NUTX) rose 11.4% to $5.18 in pre-market trading after declining 22% on Monday.
- Cenntro Electric Group Limited (NASDAQ:CENN) rose 8.8% to $1.61 in pre-market trading. Nuvve Holding Corp. and Cenntro reported an alliance to accelerate adoption of commercial electric vehicles.
- Cosmos Holdings Inc. (NASDAQ:COSM) rose 7.1% to $0.90 in pre-market trading after dropping 12% on Monday.
Don’t forget to check out our premarket coverage here .
Losers
- Upstart Holdings, Inc. (NASDAQ:UPST) shares fell 47.8% to $40.24 in pre-market trading after the company reported Q1 earnings results and issued Q2 and FY22 sales guidance below analyst estimates.
- GoodRx Holdings, Inc. (NASDAQ:GDRX) shares fell 40% to $6.45 in pre-market trading after the company Q1 earnings results and issued Q2 sales guidance below analyst estimates.
- Novavax, Inc. (NASDAQ:NVAX) fell 21% to $42.10 in pre-market trading as the company posted downbeat results for its first quarter on Monday.
- CarGurus, Inc. (NASDAQ:CARG) fell 18.7% to $24.25 in pre-market trading after the company reported Q1 earnings results and issued Q2 adjusted EPS guidance below analyst estimates.
- Blue Water Vaccines, Inc. (NASDAQ:BWV) fell 15.5% to $4.58 in pre-market trading after jumping 44% on Monday.
- Aterian, Inc. (NASDAQ:ATER) shares fell 14.5% to $3.41 in pre-market trading after the company reported worse-than-expected Q1 sales results.
- Groupon, Inc. (NASDAQ:GRPN) fell 14.4% to $13.40 in pre-market trading after the company reported weaker-than-expected results for its first quarter and issued weak FY22 sales guidance.
- Affirm Holdings, Inc. (NASDAQ:AFRM) fell 12.4% to $18.00 in pre-market trading after Upstart reported financial results and issued guidance below analyst estimates.
- LogicBio Therapeutics, Inc. (NASDAQ:LOGC) fell 7.1% to $0.62 in pre-market trading. LogicBio Therapeutics shares jumped over 34% on Monday after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, allowing patient enrollment to resume in the Phase 1/2 SUNRISE trial for pediatric patients with methylmalonic acidemia.
- OceanPal Inc. (NASDAQ:OP) fell 7% to $0.5209 in pre-market trading.
- 3D Systems Corporation (NYSE:DDD) shares fell 6.6% to $9.55 in pre-market trading after reporting Q1 results.
